Cystografin and Yaela drug interactions - a phase IV clinical study of FDA data
Summary:
We study 19 people who take Cystografin or Yaela. There is no drug interaction reported.
The phase IV clinical study analyzes what interactions people who take Cystografin and Yaela have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Cystografin?
Cystografin has active ingredients of diatrizoate meglumine. eHealthMe is studying from 19 Cystografin users for its effectiveness, alternative drugs and more.
What is Yaela?
Yaela has active ingredients of drospirenone; ethinyl estradiol.
Do you take Cystografin and Yaela?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Cystografin (19 reports)
- Yaela
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine and drospirenone; ethinyl estradiol (the active ingredients of Cystografin and Yaela, respectively), and Cystografin and Yaela (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cystografin and Yaela.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Topiramate and Vaginal Bleeding Between Periods - 8 seconds ago
- Biotin and Blood Bicarbonate Increased - 16 seconds ago
- Cimetidine and Oesophagitis - 45 seconds ago
- Escitalopram Oxalate and Blood Ph Increased - 51 seconds ago
- Appetite - Decreased in Ativan, how severe and when it was recovered? - 59 seconds ago
- Appetite Decreased in Ativan, how severe and when it was recovered? - a minute ago
- Escitalopram Oxalate and Blood Pressure Diastolic Decreased - a minute ago
- Anaemia and Muscle Tightness - 2 minutes ago
- Remeron and Systemic Inflammatory Response Syndrome - 2 minutes ago
- Sertraline Hydrochloride and Hyperthyroidism Aggravated - 3 minutes ago